The global neurotechnology market size is calculated at USD 17.32 billion in 2025 and is forecasted to reach around USD 52.86 billion by 2034, accelerating at a CAGR of 13.19% from 2025 to 2034. The North America neurotechnology market size surpassed USD 5.51 billion in 2024 and is expanding at a CAGR of 13.34% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Neurotechnology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Neurotechnology Market, by Product Type
8.1.1 Neurostimulation
8.1.1.1. Market Revenue and Forecast
8.1.2. Neurosensing
8.1.2.1. Market Revenue and Forecast
8.1.3. Neuroprostheses
8.1.3.1. Market Revenue and Forecast
8.1.4. Neurorehabilitation
8.1.4.1. Market Revenue and Forecast
9.1. Neurotechnology Market, by Conditions
9.1.1. Cognitive Disorders
9.1.1.1. Market Revenue and Forecast
9.1.2. Pain Treatment
9.1.2.1. Market Revenue and Forecast
9.1.3. Urinary and Fecal Incontinence
9.1.3.1. Market Revenue and Forecast
9.1.4. Epilepsy
9.1.4.1. Market Revenue and Forecast
9.1.5. Parkinson's disease
9.1.5.1. Market Revenue and Forecast
9.1.6. Hearing Conditions
9.1.6.1. Market Revenue and Forecast
9.1.7. Sleep Disorder
9.1.7.1. Market Revenue and Forecast
9.1.8. Depression
9.1.8.1. Market Revenue and Forecast
9.1.9. Others
9.1.9.1. Market Revenue and Forecast
10.1. Neurotechnology Market, by End-Use
10.1.1. Ambulatory surgical centers
10.1.1.1. Market Revenue and Forecast
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast
10.1.3. Homecare facilities
10.1.3.1. Market Revenue and Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type
11.1.2. Market Revenue and Forecast, by Conditions
11.1.3. Market Revenue and Forecast, by End-Use
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product Type
11.1.4.2. Market Revenue and Forecast, by Conditions
11.1.4.3. Market Revenue and Forecast, by End-Use
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product Type
11.1.5.2. Market Revenue and Forecast, by Conditions
11.1.5.3. Market Revenue and Forecast, by End-Use
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type
11.2.2. Market Revenue and Forecast, by Conditions
11.2.3. Market Revenue and Forecast, by End-Use
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product Type
11.2.4.2. Market Revenue and Forecast, by Conditions
11.2.4.3. Market Revenue and Forecast, by End-Use
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product Type
11.2.5.2. Market Revenue and Forecast, by Conditions
11.2.5.3. Market Revenue and Forecast, by End-Use
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product Type
11.2.6.2. Market Revenue and Forecast, by Conditions
11.2.6.3. Market Revenue and Forecast, by End-Use
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product Type
11.2.7.2. Market Revenue and Forecast, by Conditions
11.2.7.3. Market Revenue and Forecast, by End-Use
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type
11.3.2. Market Revenue and Forecast, by Conditions
11.3.3. Market Revenue and Forecast, by End-Use
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product Type
11.3.4.2. Market Revenue and Forecast, by Conditions
11.3.4.3. Market Revenue and Forecast, by End-Use
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product Type
11.3.5.2. Market Revenue and Forecast, by Conditions
11.3.5.3. Market Revenue and Forecast, by End-Use
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product Type
11.3.6.2. Market Revenue and Forecast, by Conditions
11.3.6.3. Market Revenue and Forecast, by End-Use
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product Type
11.3.7.2. Market Revenue and Forecast, by Conditions
11.3.7.3. Market Revenue and Forecast, by End-Use
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type
11.4.2. Market Revenue and Forecast, by Conditions
11.4.3. Market Revenue and Forecast, by End-Use
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product Type
11.4.4.2. Market Revenue and Forecast, by Conditions
11.4.4.3. Market Revenue and Forecast, by End-Use
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product Type
11.4.5.2. Market Revenue and Forecast, by Conditions
11.4.5.3. Market Revenue and Forecast, by End-Use
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product Type
11.4.6.2. Market Revenue and Forecast, by Conditions
11.4.6.3. Market Revenue and Forecast, by End-Use
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product Type
11.4.7.2. Market Revenue and Forecast, by Conditions
11.4.7.3. Market Revenue and Forecast, by End-Use
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type
11.5.2. Market Revenue and Forecast, by Conditions
11.5.3. Market Revenue and Forecast, by End-Use
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product Type
11.5.4.2. Market Revenue and Forecast, by Conditions
11.5.4.3. Market Revenue and Forecast, by End-Use
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product Type
11.5.5.2. Market Revenue and Forecast, by Conditions
11.5.5.3. Market Revenue and Forecast, by End-Use
12.1. General Electric Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Siemens Healthcare Private Limited
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Shimadzu Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Koninklijke Philips N.V.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Hitachi Medical Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Elekta AB
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Toshiba Medical Systems Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Tristan Technologies, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample